<qa>  What will the subject undergo?The subject will return to the study office the next day for their second treatment visit. The study staff will review the subjects diary and record their vital signs. The subjects take home diary will be re-dispensed. The subject will then undergo the same infusion procedure as in their first treatment visit. Subjects will again receive a total of 1000mg of Depacon IV. Subjects will be closely monitored and repeatedly queried for the development of adverse events. Appropriate intervention and follow-up will be applied as deemed necessary by the investigator. 